Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Investing in Health Tech & Digital Medicine: Expert Talk with Mikaela Odlander & Edward Kliphuis

Investing in Health Tech & Digital Medicine: Expert Talk with Mikaela Odlander & Edward Kliphuis

FromBack Bay Life Science Report


Investing in Health Tech & Digital Medicine: Expert Talk with Mikaela Odlander & Edward Kliphuis

FromBack Bay Life Science Report

ratings:
Length:
29 minutes
Released:
Apr 14, 2023
Format:
Podcast episode

Description

The world of health tech has changed dramatically since decades ago when physicians had to endure 11 keystrokes to prescribe a single aspirin. These days, AI-based radiology and AI-based pathology are transforming patient lives through machine learning and data analytics, in some cases offering early disease warning systems and improving quality of care while reducing healthcare costs.   In this episode of Back Bay’s industry podcast, the Life Science Report, Jonathan Gertler speaks with Mikaela Odlander, Director of Digital Therapeutics at Orexo, and Edward Kliphuis, Partner at Sofinnova Partners, about the opportunities and challenges ahead in the realm of health tech and digital medicine.  Topics in this episode include:  - The misperceptions around digital therapeutics and digital medicine- The impact health tech has on care, fostering adoption, hurdles to reimbursement- The stark difference between the European and Nordic vs. US healthcare markets- Examples of AI machine learning and how digital medicine is providing personalized, efficient and effective healthcare- The major challenge of replication and scale for a company
Released:
Apr 14, 2023
Format:
Podcast episode

Titles in the series (27)

Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.